LATAM Medtech Leaders
by Julio G. Martinez-Clark
Since Mar 18, 2019 04:00 UTC
Latin America is undergoing dramatic demographic and epidemiological changes. Its population is rapidly aging, and there is a worrisome increase in the prevalence of chronic diseases. Despite this, innovative medical technologies sometimes take years to reach these patients. US and European Medical technology (“Medtech”) companies struggle to find a cost-effective first-in-human clinical research center or to gain market share in Latin America; this prevents patients in Latin America from having faster and easier access to innovative and breakthrough medical technologies.We realized that a) the majority of US and European small and mid-size Medtech companies fail in their attempt to enter Latin America; b) that these companies have no source of quality, reliable, and actionable information on how to reach the right patients in the region, c) that these companies have a hard time finding an expert to guide them to succeed in the region. As a consequence, patients in Latin America have delayed access to breakthrough and innovative medical technologies. We decided to create this podcast to fix these problems by becoming part of the solution to accelerate the penetration of breakthrough medical innovations in Latin America.
Categories: Business, Health & Fitness
Tags: brazil, Clinical Research, clinical trials, Colombia, Commercialization, FDA, first-in-human, Healthcare, LATAM Medtech Leaders Podcast, Latin America, Medical Devices, medical innovation, medtech, mexico, regulatory
+ Read more
